Add
AMPE to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| AMPE > SEC Filings for AMPE > Form 8-K on 10-Jul-2012 | All Recent SEC Filings |
10-Jul-2012
Regulation FD Disclosure, Other Events, Financial Statements and Exhi
On July 9, 2012, Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") issued a press release announcing results from the Company's further analysis of its Optina ™ clinical trial to treat diabetic macular edema, a copy of which press release is furnished as Exhibit 99.1 to this report.
The information contained in this Item 7.01 and Exhibit 99.1 to this report shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any filings made by Ampio under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as may be expressly set forth by specific reference in such filing.
On July 9, 2012, Ampio announced results from further analysis of its previously concluded clinical study of Optina™ to treat diabetic macular edema. Ampio's results indicate that there is a clinically meaningful reduction in edema at the appropriate dosage and this is paralleled by an improvement in visual acuity. The results will help Ampio in its planning of the next trial, which it intends to discuss with the Food and Drug Administration (FDA) later this month to clarify the path for approval for Optina ™.
(d) Exhibits.
The following exhibit is furnished with this report:
99.1 Press Release dated July 9, 2012
This Current Report on Form 8-K and Exhibit 99.1 contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by use of terms such as "may," "project," "should," "plan," "expect," "anticipate" "believe," "estimate" and similar words, although some forward-looking statements are expressed differently. Forward-looking statements represent our management's judgment regarding future events. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, the Company can give no assurance that such expectations will prove to be correct. All statements other than statements of historical fact included in this Current Report on Form 8-K and in Exhibit 99.1 are forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The Company cannot guarantee the accuracy of the forward-looking statements, and you should be aware that the Company's actual results could differ materially from those contained in forward-looking statements due to a number of factors, including the statements under "Risk Factors" found in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 9, 2012, and its Form 10-Qs on file with the SEC.
|
|